Recruiting Myelofibrosis Studies in Denver
About Myelofibrosis Clinical Trials in Denver
Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.
There are currently 1 myelofibrosis clinical trials recruiting participants in Denver, COLORADO. These studies are seeking a combined 240 participants. Research is being sponsored by Sumitomo Pharma America, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelofibrosis Clinical Trials in Denver — FAQ
Are there myelofibrosis clinical trials in Denver?
Yes, there are 1 myelofibrosis clinical trials currently recruiting in Denver, COLORADO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Denver?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you about next steps.
Are clinical trials in Denver free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Denver studies also compensate for your time and travel.
What myelofibrosis treatments are being tested?
The 1 active trials in Denver are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov